FindTrial
Sign In

The influence of ultrasound-guided abdominal regional nerve block optimization for postoperative pain and forward prognosis

The influence of ultrasound-guided abdominal regional nerve block optimization for postoperative pain and forward prognosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011160
Enrollment
Unknown
Registered
2017-04-16
Start date
2017-04-17
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal surgery

Interventions

control group:only PCIA for analgesia
TAP regular group:0.375% ropivacaine
TAP fentanyl group:0.375% ropivacaine combined with fentanyl
TAP dex group:0.375% ropivacaine combined with Dexmedetomidine

Sponsors

Department of Anesthesiology, ChongQing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years who underwent open operation of gynecologic malignant tumors were enrolled in an informed consent from at the ASA I-II.

Exclusion criteria

Exclusion criteria: Patient's refusal,coagulopathy,infection at the needle insertion,allergy to local anesthetics.

Design outcomes

Primary

MeasureTime frame
first bolus time of PCA postoperation;QoR-40 questionnaire;—

Secondary

MeasureTime frame
score of VAS postoperation;total use of opioids postoperation;—

Countries

China

Contacts

Public ContactYang Bin

ChongQing Cancer Hospital

amyangbin@163.com+86 18581288032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026